DailyTickers

CORZ — Core Scientific, Inc.

NASDAQ · Technology · August 28, 2026
$17.11 +0.06% AI/HPC infrastructure beta WATCH Score 59 C+
$5.50B
Market Cap
15.1M
Volume
5.592
Beta
$13.13 – $30.46
52W Range
22.3%
Short Interest
$37.13
Analyst Target
CORZ Chart
Click to enlarge

Verdict Express

C+ Bullish Moderate confidence

Core Scientific now has a visible colocation business rather than merely a mining conversion story. Q2 2026 revenue rose to $164.2 million from $78.6 million, colocation contributed $136.7 million, gross profit reached $70 million and non-GAAP adjusted EBITDA was $41.1 million. Billing capacity was 395 MW in Q2 and 437 MW by mid-July, supporting an annualized colocation GAAP revenue run rate near $635 million. The AMD partnership adds a 530 MW, 15-year anchor with more than $14 billion of potential base contract value, taking total leased power to 1.1 GW. The contradiction is cash intensity: Q2 capex was $797.5 million, trailing EBITDA remains negative in the point-in-time bundle, and the $1.155 billion GAAP net loss was distorted by fair-value changes on pre-existing warrants. An August facility added a $100 million revolver and $500 million letter-of-credit line with a $150 million liquidity floor but no new warrants. The C+ grade recognizes operating conversion but not yet mature returns. Trade status remains watch above $17.45.

Why Buy

  • Q2 revenue was $164.2M versus $78.6M a year earlier.
  • Colocation revenue reached $136.7M and gross profit $70M.
  • Non-GAAP adjusted EBITDA was $41.1M.
  • Billing capacity reached 437 MW by mid-July.
  • Total leased power reached 1.1 GW with more than $24B potential base value.

Why Avoid

  • Q2 GAAP net loss was $1.155B, heavily affected by warrant fair value.
  • Q2 capital expenditure was $797.5M.
  • The point-in-time bundle still shows negative trailing EBITDA.
  • The August credit package imposes a $150M minimum-liquidity covenant.
  • Two warrant classes tied to financing create additional per-share complexity.

Business Overview

Core Scientific develops high-density datacenters and sells colocation capacity under long-term contracts, while retaining a smaller digital-asset mining operation. Revenue is driven by billable megawatts, contractual pricing, power pass-throughs, uptime and residual mining hash economics.

The AI transmission channel is direct: customers such as CoreWeave and AMD reserve power and datacenter infrastructure, Core Scientific funds the conversion and build, and contracted fees begin as capacity is delivered. Billing power of 437 MW in mid-July versus 1.1 GW leased quantifies the remaining conversion runway.

The model breaks if construction is late, customer credit weakens, equipment or grid delivery fails, or financing covenants constrain the build. Potential contract value above $24B is undiscounted and delivered over many years. Warrant accounting can obscure operating results, while actual capex and liquidity determine whether common shareholders capture the residual economics. Investors should therefore track billing megawatts, customer acceptance, incremental rent and remaining construction cost together, rather than valuing the entire leased pipeline at an undiscounted contract headline.

Segments

SegmentRevenueDescription
ColocationIssuer-reported operating segment providing high-density services to AI and HPC customers.
Digital Asset Self-MiningIssuer-reported operating segment using owned machines to mine bitcoin.
Digital Asset Hosted MiningIssuer-reported operating segment hosting third-party mining equipment.

Recent News

2026-07-28
Core Scientific reports Q2 2026 results positive
Colocation becoming 83% of revenue improves visibility, although $797.5M of quarterly capex keeps free cash flow under pressure.
Core Scientific official release
2026-07-28
AMD partnership anchors 530 MW for 15 years positive
The agreement lifts leased power to 1.1 GW but requires substantial funded construction before potential contract value becomes revenue.
Core Scientific official release
2026-08-27
Core Scientific closes $600M of credit facilities neutral
The revolver and letter-of-credit facility support buildout while adding covenants and liquidity restrictions; they issued no new warrants.
SEC Form 8-K

Fundamentals

MetricValueSignal
Q2 revenue$164.2M+109% YoY
Q2 colocation revenue$136.7M83% of total
Q2 adjusted EBITDA$41.1MNon-GAAP
Q2 capital expenditure$797.5MBuildout burden
Price/Sales~12.5x trailingAugust 28, 2026 basis; 12.5x versus APLD 12.5x and CRWV 5.3x trailing sales
EV/Revenue~18.7x trailingAugust 28, 2026 basis; 18.7x versus APLD 21.9x and CRWV 12.4x trailing EV/revenue
Revenue (TTM)$440.3M108.8% YoY
Gross Margin32.1%Reported
Operating Margin6.9%Profitable
Net MarginN/ANot reliably available
ROE0.0%Capital efficiency
Cash$1.77BLiquidity; sector accounting may limit direct debt netting
Debt$4.41BBalance-sheet claim
Intrinsic-value modelN/AFail-closed: insufficient or non-economic output
Value / quality panel0 positive / 5 negative / 0 neutralbearish / confidence 52
Fundamental grade audit59/100 (C+)base +55, growth +14, grossMargin +2, operatingMargin +5, earningsGrowth +0, roe +0, balanceSheet +0, qualityBoard -6, capitalStructure -1, controls -8; capped score 59/100

Earnings History

QuarterEPS ActualEPS Est.SurpriseRevenue
3Q2025$-0.20$0.07-382.9%-
4Q2025$-0.18$-0.12-53.4%-
1Q2026$-0.11$-0.05-119.6%-
2Q2026$-0.04$-0.0627.2%-

Q2 2026 revenue was $164.2M versus $78.6M, with colocation revenue of $136.7M versus $10.6M. Gross profit increased to $70M from $5M, and non-GAAP adjusted EBITDA reached $41.1M versus $28.5M. GAAP net loss was $1.155B, primarily reflecting non-cash warrant fair-value movements rather than operating cash burn. Billing capacity was 395 MW in Q2 and 437 MW by mid-July, equivalent to approximately $635M of annualized colocation GAAP revenue. Core Scientific reported billing-run-rate milestones but no formal consolidated revenue or EBITDA guidance. The caveat is investment intensity: Q2 capex was $797.5M, and the 530 MW AMD build must be financed and delivered before its potential value is earned. No confirmed Core Scientific next-results date was shown in the official investor calendar reviewed. — Next: Not confirmed

Insiders & Institutions

3.1%
Insider Own.
119.7%
Institution Own.

Recent Transactions

DateInsiderTypeSharesValue
2026-08-20CRAIN ELIZABETHbuy6,000$109,980
2026-08-18Weiss Eric Stantonbuy7,000$134,330
2026-08-17DUCHENE TODD Msell10,000$201,000
2026-08-10DUCHENE TODD Msell10,000$199,700
2026-08-03DUCHENE TODD Msell10,000$222,300
2026-07-27DUCHENE TODD Msell10,000$209,500
2026-07-20DUCHENE TODD Msell10,000$223,000
2026-07-13DUCHENE TODD Msell10,000$224,500

Structured transactions shown; grants and sales are not treated as thesis confirmation.

Capital Structure & Dilution

321.3M
Shares Out.
See filing review
Authorized
moderate
Dilution Risk

Core Scientific's June filing used 325.3M weighted-average basic shares and listed 182.7M potentially dilutive shares excluded from EPS: 69.6M from converts, 16.4M awards, 0.3M options and 96.4M Tranche 1 warrants. That produces an approximately 508.0M minimum observable diluted pro-forma denominator, 56.2% above basic; 6.6M penny-warrant shares were already included in basic EPS. The August $100M revolver and $500M letter-of-credit facility had no amount drawn at closing and issued no new warrants. The two listed warrant classes are 2024 restructuring securities, not financing-linked August instruments.

SEC Filings Review

3 decision-relevant primary filing(s) are displayed with accession-specific findings. Grade C+ measures fundamentals; trade state watch measures timing and is evaluated separately.

DateFormAccessionWhat the filing changes
2026-07-2810-Q0001839341-26-000014The June Form 10-Q reports Q2 revenue of $164.2M, colocation revenue of $136.7M, project spending and warrant accounting, establishing current operating and liquidity risk. This classification controls the editorial conclusion.
2026-03-1810-K/A0001628280-26-019505The amended 2025 Form 10-K establishes Core Scientific's annual controls, warrants, debt and post-reorganization baseline; it predates the Q2 AMD lease and August credit facilities.
2026-08-278-K0001839341-26-000021The August Form 8-K documents an undrawn-at-closing $100M secured revolver and $500M letter-of-credit facility plus a $150M liquidity floor. It creates debt and covenant capacity but discloses no new financing-linked warrant issuance; existing CORZW and CORZZ are pre-existing restructuring warrants.

Contrarian checks

Short Interest

22.3%
SI % Float
5.54
Days to Cover
N/A
CTB

CORZ point-in-time short-interest context only; no acceleration claim without a comparable dated series.

Options / Derivatives

28,536
Call OI
24,473
Put OI
1.17
C/P Ratio
$18.50
Max Pain
N/A
IV Mean

Unusual Activity: No unusual activity confirmed

Technical Analysis

RSI (14)31.1
EMA 20$19.39
EMA 50$21.19
EMA 200$20.05
MACD-1.326
Signal-1.217
ATR (14)$1.23
WyckoffTransitional
RSI 31.1 WATCH AI/HPC infrastructure beta
Supports: $14.43 / $16.41 / $16.91
Resistances: $17.45 / $18.52 / $21.66

Technical Setup

CORZ activates only on a completed 15-minute close beyond $17.45 with non-zero RTH volume. The structural stop is the published $16.91 support, traced to the October 23, 2025 low at $16.9099; targets are the August 27 high at $18.52 and August 12 high at $21.6599. Core Scientific printed $17.11 at 2026-08-28T13:45:03Z; no later bar enters the structure. Financing news vetoes activation. Daily indicators and pivots run only through the 2026-08-27 close.

Performance & Benchmarks

21.0%
YTD
24.1%
1Y
N/A — insufficient aligned history
3Y
Not calculated without aligned benchmark bars.
Alpha

Macro Context

IndicatorValueSignal
Reference close2026-08-27Daily structure is point-in-time controlled
Quote snapshot2026-08-28T13:45:03ZExact timestamp; not represented as a publication-time live quote
Opening observation2026-08-28T13:30:00ZRegular-session range used for the single activation level

Regime: risk-on

Core Scientific converts existing grid access from bitcoin mining into long-duration AI colocation. Hyperscaler demand drives leasing, but transformer availability, construction inflation and credit spreads determine delivery cost; bitcoin price still affects residual mining cash flow.

Risk Analysis

Risk Profile: Moderate

Core Scientific has validated colocation demand, but 1.1 GW leased greatly exceeds current billing capacity and requires sustained capital. Warrants, covenants and large capex can prevent contract growth from translating cleanly into per-share cash flow.

Conversion gap

High
  • 437 MW was billing versus 1.1 GW leased.
  • AMD alone requires a 530 MW build.
Probability
Impact
Leased power creates value only after funded capacity reaches formal customer acceptance.

Financing covenants

High
  • The package adds $600M of facilities.
  • A $150M liquidity floor constrains cash use.
Probability
Impact
Debt capacity improves execution only while covenant headroom and the required liquidity floor remain comfortably intact.

Warrant distortion

Medium
  • Q2 GAAP loss was $1.155B.
  • Warrant fair value drove much of the loss.
Probability
Impact
Use operating cash flow while still pricing warrant dilution and accounting volatility.

Risk Synthesis

Separate contracted from billing megawatts. Retail war-room: use a small position and limit only after $17.45 confirms, budget spread and slippage through $16.91, and never chase an AMD headline. A financing-filing event, customer gap or thin opening book cancels the trade until terms and regular-session liquidity are reviewed.

Social Radar

Stocktwits
30
neutral
14298 watchers; not used as a trigger.
Aggregate sentiment
2
positive
Confidence 21.0%.

Pump & Dump Score: 4/6

Alert P&D
SEC issuer mapping complete
Short interest below 20%
SEC-reviewed dilution risk is moderate

Capital Flow

N/A
Net Flow
N/A
Institutional
N/A
Retail
N/A
Dark Pool %

CORZ: directional flow remains unscored because no dated, inspectable transaction-level source was captured.

Trade Idea

WATCH — Watch $17.45: activation requires a completed 15-minute close above it with non-zero regular-session volume.
Entry Zone
$17.45
Single activation level $17.45 from the observed RTH opening range. Quote snapshot $17.11 at 2026-08-28T13:45:03Z. Watch $17.45: activation requires a completed 15-minute close above it with non-zero regular-session volume. Stop basis: 2025-10-23 dated low at $16.9099, published support rounded to $16.91 TP1 basis: 2026-08-27 session high at $18.52 TP2 basis: 2026-08-12 swing high at $21.6599
Stop Loss
$16.91
-3.1%
Target 1
$18.52
+6.1%
Target 2
$21.66
+24.1%
Risk/Reward
1:1.98 to TP1 / 1:7.80 to TP2
10 trading sessions after activation

Thesis

Keep the setup inactive until a completed 15-minute close above $17.45 with non-zero regular-session volume confirms sponsorship. Only then do the $16.91 structural stop and $18.52/$21.6599 dated-pivot targets govern. Reduce size for $797.5M quarterly capex, the leased-versus-billing gap and another covenant-bearing funding event. Undelivered megawatts do not fund near-term obligations.

Catalysts

  • Additional leased capacity moving into billing
  • AMD construction milestones staying funded and on schedule
  • Colocation EBITDA growing faster than capex needs

Invalidation

  • Hard stop $16.91 only after valid activation
  • Customer delay or material construction overrun
  • Covenant pressure or financing that worsens warrant dilution

Global Score

C+ AI/HPC infrastructure beta Bullish

Key Takeaways — Positive

  • Q2 colocation revenue reached $136.7M and adjusted EBITDA $41.1M.
  • 437 MW was billing by mid-July.
  • Total leased power of 1.1 GW carries more than $24B potential base value.

Key Takeaways — Risks

  • Q2 capex was $797.5M.
  • Warrants drove a $1.155B GAAP loss and add dilution complexity.
  • Negative trailing EBITDA and a 1.1 GW delivery burden limit the C+ grade.

Mindset Tip

Separate contracted from billing megawatts. Current trade state: watch.

Disclaimer

This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.

Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Data comes from point-in-time market snapshots, company filings, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.

Verdict Business News Fundamentals Earnings Insiders Capital SEC Review Technical Perf Risks Social Flow Trade Score